Meagan E. Gray

Gastroenterology

2000 6th Ave S
Birmingham, AL 35233

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Journal: Alimentary pharmacology & therapeutics

Published: February 02, 2026

Screening for Hepatocellular Carcinoma Recurrence After Liver Transplantation: Prospective Validation of Binary Criteria.

Screening for Hepatocellular Carcinoma Recurrence After Liver Transplantation: Prospective Validation of Binary Criteria.

Journal: Cancer medicine

Published: May 17, 2025

The pleiotropic effects of glucagon-like peptide-1 receptor agonists in patients with metabolic dysfunction-associated steatohepatitis: a review for gastroenterologists.

The pleiotropic effects of glucagon-like peptide-1 receptor agonists in patients with metabolic dysfunction-associated steatohepatitis: a review for gastroenterologists.

Journal: Expert opinion on investigational drugs

Published: February 28, 2025

Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.

Larsucosterol for the Treatment of Alcohol-Associated Hepatitis.

Journal: NEJM evidence

Published: January 28, 2025

Metabolic characteristics of patients with MetALD: Caveats of a new definition.

Metabolic characteristics of patients with MetALD: Caveats of a new definition.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 04, 2024

Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).

Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).

Journal: Gastroenterology

Published: January 31, 2024

Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race.

Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race.

Journal: Obesity (Silver Spring, Md.)

Published: September 07, 2023

Metabolic dysfunction associated steatotic liver disease: Current practice, screening guidelines and management in the primary care setting.

Metabolic dysfunction associated steatotic liver disease: Current practice, screening guidelines and management in the primary care setting.

Journal: The American journal of the medical sciences

Published: July 29, 2023

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?

Levetiracetam Liver Injury: A Benign Antiepileptic Agent?

Journal: ACG case reports journal

Published: October 28, 2022

Harmonized Multisite MRI-Based Quantification of Human Liver Fat and Stiffness: A Pilot Study.

Harmonized Multisite MRI-Based Quantification of Human Liver Fat and Stiffness: A Pilot Study.

Journal: Journal of magnetic resonance imaging : JMRI

Published: September 29, 2022

Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients.

Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients.

Journal: Metabolism and target organ damage

Published: August 26, 2022

Gastric Xanthomatosis Secondary to Lipoprotein X in Primary Biliary Cholangitis.

Gastric Xanthomatosis Secondary to Lipoprotein X in Primary Biliary Cholangitis.

Journal: Journal of investigative medicine high impact case reports

Published: April 11, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026